Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients

NCT03899389 is registered in ClinicalTrials.gov with Gdansk University of Physical Education and Sport as lead sponsor.

NCT NCT03899389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients
Lead sponsor
Gdansk University of Physical Education and Sport
Phase
Observational
Overall status
Completed
Start date
February 1, 2017
Completion date
May 31, 2018
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease